
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11921663
[patent_doc_number] => 09789224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Compositions and methods for cardiac therapy'
[patent_app_type] => utility
[patent_app_number] => 13/217218
[patent_app_country] => US
[patent_app_date] => 2011-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12568
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217218 | Compositions and methods for cardiac therapy | Aug 23, 2011 | Issued |
Array
(
[id] => 7744339
[patent_doc_number] => 20120022020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'PHARMACEUTICAL FORMS FOR THE RELEASE OF ACTIVE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/193977
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21165
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022020.pdf
[firstpage_image] =>[orig_patent_app_number] => 13193977
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/193977 | Pharmaceutical forms for the release of active compounds | Jul 28, 2011 | Issued |
Array
(
[id] => 8853196
[patent_doc_number] => 20130142871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'ORAL DOSAGE FORM OF DEFERASIROX'
[patent_app_type] => utility
[patent_app_number] => 13/807738
[patent_app_country] => US
[patent_app_date] => 2011-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7371
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807738 | Oral dosage form of deferasirox | Jul 6, 2011 | Issued |
Array
(
[id] => 8767143
[patent_doc_number] => 20130095180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'TIME-DELAYED SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING DAPOXETINE FOR ORAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/805028
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6681
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805028 | TIME-DELAYED SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING DAPOXETINE FOR ORAL ADMINISTRATION | Jul 4, 2011 | Abandoned |
Array
(
[id] => 7719905
[patent_doc_number] => 20120009240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Films for Delivery of a Therapeutic Agent'
[patent_app_type] => utility
[patent_app_number] => 13/173718
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10019
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009240.pdf
[firstpage_image] =>[orig_patent_app_number] => 13173718
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/173718 | Films for Delivery of a Therapeutic Agent | Jun 29, 2011 | Abandoned |
Array
(
[id] => 10089021
[patent_doc_number] => 09125824
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-09-08
[patent_title] => 'Methods and systems for processing organic trans-resveratrol as dietary supplements'
[patent_app_type] => utility
[patent_app_number] => 13/173927
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4002
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173927
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/173927 | Methods and systems for processing organic trans-resveratrol as dietary supplements | Jun 29, 2011 | Issued |
Array
(
[id] => 7510107
[patent_doc_number] => 20110256190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Modified release compositions comprising tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 13/167334
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24459
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256190.pdf
[firstpage_image] =>[orig_patent_app_number] => 13167334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167334 | Modified release compositions comprising tacrolimus | Jun 22, 2011 | Issued |
Array
(
[id] => 9183478
[patent_doc_number] => 08623410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Modified release compositions comprising tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 13/167160
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24566
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167160
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167160 | Modified release compositions comprising tacrolimus | Jun 22, 2011 | Issued |
Array
(
[id] => 7487854
[patent_doc_number] => 20110251232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Modified release compositions comprising tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 13/167281
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24450
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251232.pdf
[firstpage_image] =>[orig_patent_app_number] => 13167281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167281 | Modified release compositions comprising tacrolimus | Jun 22, 2011 | Issued |
Array
(
[id] => 7487850
[patent_doc_number] => 20110251231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Modified release compositions comprising tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 13/167095
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24446
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13167095
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167095 | Modified release compositions comprising tacrolimus | Jun 22, 2011 | Issued |
Array
(
[id] => 9383516
[patent_doc_number] => 20140086997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRACEUTICAL DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/118078
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12004
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118078
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118078 | Coating composition suitable for pharmaceutical or nutraceutical dosage forms | Jun 16, 2011 | Issued |
Array
(
[id] => 7490762
[patent_doc_number] => 20110237675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'PHARMACEUTICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/151555
[patent_app_country] => US
[patent_app_date] => 2011-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7294
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237675.pdf
[firstpage_image] =>[orig_patent_app_number] => 13151555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/151555 | PHARMACEUTICAL FORMULATIONS | Jun 1, 2011 | Abandoned |
Array
(
[id] => 7579838
[patent_doc_number] => 20110293721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'PIROXICAM-CONTAINING MATRIX PATCHES AND METHODS FOR THE TOPICAL TREATMENT OF ACUTE AND CHRONIC PAIN AND INFLAMMATION THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/115898
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19751
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293721.pdf
[firstpage_image] =>[orig_patent_app_number] => 13115898
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/115898 | Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith | May 24, 2011 | Issued |
Array
(
[id] => 8963110
[patent_doc_number] => 20130202711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'Substance-encapsulating vesicle and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 13/699238
[patent_app_country] => US
[patent_app_date] => 2011-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 28907
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699238
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699238 | Substance-encapsulating vesicle and process for producing the same | May 22, 2011 | Issued |
Array
(
[id] => 7586426
[patent_doc_number] => 20110280936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'Self Breaking Tablets'
[patent_app_type] => utility
[patent_app_number] => 13/104218
[patent_app_country] => US
[patent_app_date] => 2011-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6021
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280936.pdf
[firstpage_image] =>[orig_patent_app_number] => 13104218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/104218 | Self Breaking Tablets | May 9, 2011 | Abandoned |
Array
(
[id] => 7560919
[patent_doc_number] => 20110274751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES'
[patent_app_type] => utility
[patent_app_number] => 13/099878
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2462
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274751.pdf
[firstpage_image] =>[orig_patent_app_number] => 13099878
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/099878 | TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES | May 2, 2011 | Abandoned |
Array
(
[id] => 11449143
[patent_doc_number] => 09572769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Polymer-liposome nanocomposite composition for percutaneous absorption, and method for preparing same'
[patent_app_type] => utility
[patent_app_number] => 13/640608
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3776
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640608 | Polymer-liposome nanocomposite composition for percutaneous absorption, and method for preparing same | Apr 11, 2011 | Issued |
Array
(
[id] => 6167980
[patent_doc_number] => 20110196043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'METHODS AND COMPOSITIONS FOR ADMINISTRATION OF TRPV1 AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/083294
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27859
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196043.pdf
[firstpage_image] =>[orig_patent_app_number] => 13083294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083294 | Methods and compositions for administration of TRPV1 agonists | Apr 7, 2011 | Issued |
Array
(
[id] => 5959682
[patent_doc_number] => 20110184069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR ADMINISTRATION OF TRPV1 AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/083306
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27877
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184069.pdf
[firstpage_image] =>[orig_patent_app_number] => 13083306
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083306 | Methods and compositions for administration of TRPV1 agonists | Apr 7, 2011 | Issued |
Array
(
[id] => 8405391
[patent_doc_number] => 20120237447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'STAR POLYMER NANOSHELLS AND METHODS OF PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/051083
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 24449
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13051083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/051083 | Star polymer nanoshells and methods of preparation thereof | Mar 17, 2011 | Issued |